Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1988 Mar 12;296(6624):761–764. doi: 10.1136/bmj.296.6624.761

New Drugs: Adverse reactions. I

D N Bateman, S Chaplin
PMCID: PMC2545375  PMID: 3126965

Full text

PDF
761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman D. N., Rawlins M. D., Simpson J. M. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom. Q J Med. 1986 Jun;59(230):549–556. [PubMed] [Google Scholar]
  2. Bateman D. N., Rawlins M. D., Simpson J. M. Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) 1985 Oct 5;291(6500):930–932. doi: 10.1136/bmj.291.6500.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Colin Jones D. G., Langman M. J., Lawson D. H., Vessey M. P. Post-marketing surveillance of the safety of cimetidine: twelve-month morbidity report. Q J Med. 1985 Mar;54(215):253–268. [PubMed] [Google Scholar]
  4. Colin-Jones D. G., Langman M. J., Lawson D. H., Vessey M. P. Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up. Br Med J (Clin Res Ed) 1985 Oct 19;291(6502):1084–1088. doi: 10.1136/bmj.291.6502.1084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet. 1981 Mar 7;1(8219):541–546. [PubMed] [Google Scholar]
  6. Goudie B. M., Birnie G. F., Watkinson G., MacSween R. N., Kissen L. H., Cunningham N. E. Jaundice associated with the use of benoxaprofen. Lancet. 1982 Apr 24;1(8278):959–959. doi: 10.1016/s0140-6736(82)91953-5. [DOI] [PubMed] [Google Scholar]
  7. Hindson C., Daymond T., Diffey B., Lawlor F. Side effects of benoxaprofen. Br Med J (Clin Res Ed) 1982 May 8;284(6326):1368–1369. doi: 10.1136/bmj.284.6326.1368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. J R Coll Gen Pract. 1983 Feb;33(247):75–82. [PMC free article] [PubMed] [Google Scholar]
  9. Inman W. H., Rawson N. S. Deafness with enalapril and prescription event monitoring. Lancet. 1987 Apr 11;1(8537):872–872. doi: 10.1016/s0140-6736(87)91664-3. [DOI] [PubMed] [Google Scholar]
  10. Meirik O., Lund E., Adami H. O., Bergström R., Christoffersen T., Bergsjö P. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet. 1986 Sep 20;2(8508):650–654. doi: 10.1016/s0140-6736(86)90166-2. [DOI] [PubMed] [Google Scholar]
  11. Mikulaschek W. M. Long-term safety of benoxaprofen. J Rheumatol Suppl. 1980;6:100–107. [PubMed] [Google Scholar]
  12. Peden N. R., Cargill J. M., Browning M. C., Saunders J. H., Wormsley K. G. Male sexual dysfunction during treatment with cimetidine. Br Med J. 1979 Mar 10;1(6164):659–659. doi: 10.1136/bmj.1.6164.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
  14. Rawlins M. D. Postmarketing surveillance of adverse reactions to drugs. Br Med J (Clin Res Ed) 1984 Mar 24;288(6421):879–880. doi: 10.1136/bmj.288.6421.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rowland M. G., Stevenson C. J. Exfoliative dermatitis and practolol. Lancet. 1972 May 20;1(7760):1130–1130. doi: 10.1016/s0140-6736(72)91482-1. [DOI] [PubMed] [Google Scholar]
  16. Taggart H. M., Alderdice J. M. Fatal cholestatic jaundice in elderly patients taking benoxaprofen. Br Med J (Clin Res Ed) 1982 May 8;284(6326):1372–1372. doi: 10.1136/bmj.284.6326.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Venning G. R. Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed) 1983 Jan 22;286(6361):289–292. doi: 10.1136/bmj.286.6361.289. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES